Preliminary results of a European multicentre phase 1 study with Oncofid-P-B for the treatment of BCG unresponsive carcinoma in situ (CIS) of bladder at the end of 12 consecutive weeks intensive course and during ongoing monthly maintenance phase

Preliminary results of a European multicentre phase 1 study with Oncofid-P-B for the treatment of BCG unresponsive carcinoma in situ (CIS) of bladder at the end of 12 consecutive weeks intensive course and during ongoing monthly maintenance phase

Bibliographic Details
Main Authors: R. Hurle, G. Guazzoni, P. Colombo, A. Santoro, O. De Cobelli, E. Di Trapani, G. Nohales, L. Carlos, R. Duran-Merino, M. Lazzeri
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320333681

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320333681

Similar Items